45 results
SC 14D9/A
SNCE
Science 37 Holdings Inc
4 Mar 24
Tender offer solicitation (amended)
6:01am
as a capital markets advisor to Science 37. In the two years prior to the date of its written opinion, except for William Blair’s current engagement … and to indemnify William Blair against certain potential liabilities arising out of its engagement, including certain liabilities under the U.S. federal
SC 14D9
SNCE
Science 37 Holdings Inc
12 Feb 24
Tender offer solicitation
9:03am
a meeting, with members of Science 37’s senior management, including the Chief Legal Officer, present, to discuss the engagement of a financial advisor … , the Strategic Committee approved, and recommended the Science 37 Board approve, the engagement of William Blair as Science 37’s financial advisor
SC TO-T
EX-99
SNCE
Science 37 Holdings Inc
12 Feb 24
Third party tender offer statement
8:16am
current industry needs around patient recruitment, retention, representation, and engagement. To expand clinical trial access, Science 37 offers … engagement, the Information Agent may contact holders of Shares by personal interview, mail, electronic mail, telephone or other methods of electronic
SC14D9C
EX-99.2
SNCE
Science 37 Holdings Inc
29 Jan 24
Written communication relating to third party tender offer
4:10pm
to know:
Expanded Capabilities: eMed brings an extensive patient network that will expand our access to new participants, patient engagement technology
SC14D9C
EX-99.4
SNCE
Science 37 Holdings Inc
29 Jan 24
Written communication relating to third party tender offer
4:10pm
to new participants, patient engagement technology that will streamline our participant experience, and capital to expand our capabilities and ensure long
SC14D9C
EX-99.6
ecle38ps5w
29 Jan 24
Written communication relating to third party tender offer
4:10pm
SC14D9C
EX-99.5
ok3bf
29 Jan 24
Written communication relating to third party tender offer
4:10pm
SC TO-I
EX-99
m749wfxyj4l8u2n
3 Apr 23
Issuer tender offer statement
8:00am
8-K
EX-99.1
rxoj1t7hwo
10 Nov 22
Science 37 Reports Third Quarter 2022 Financial Results
4:05pm
424B3
hp49 fly3ihy0
12 Sep 22
Prospectus supplement
8:25am
8-K
931 tsdadkie8yu
12 Sep 22
Science 37 Names Industry Veteran Michael Shipton as Chief Commercial Officer
7:59am
8-K
EX-99.1
le9fe1ejl
12 Sep 22
Science 37 Names Industry Veteran Michael Shipton as Chief Commercial Officer
7:59am
424B3
57lmjt 9b
4 May 22
Prospectus supplement
12:43pm
424B3
qvpfxzph7f7m7s
27 Apr 22
Prospectus supplement
4:19pm
POS AM
ajjfa1hdo0fvase
8 Apr 22
Prospectus update (post-effective amendment)
4:41pm
DEF 14A
n2sjz
23 Mar 22
Definitive proxy
8:30am
424B3
pxi v283ug
22 Mar 22
Prospectus supplement
7:28am